
DBV Technologies S.A. — Investor Relations & Filings
DBV Technologies is a clinical-stage company focused on developing treatments for food allergies. Its core technology is the proprietary Viaskin patch, an investigational platform for epicutaneous immunotherapy (EPIT). This technology is designed to administer allergens to intact skin, aiming to re-educate the immune system and induce tolerance without significant transfer of the antigen into the bloodstream. The company's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergy. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, which has completed early-stage clinical studies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-05 | English | |
| S-8 - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-04 | English | |
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-04-30 | English | |
| 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-03-26 | English | |
| 8-K - DBV TECHNOLOGIES S.A. (0001613780) (Filer) | 2026-03-02 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41519264 | 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-05 | English | ||
| 41052983 | S-8 - DBV Technologies S.A. (0001613780) (Filer) | 2026-05-04 | English | ||
| 39236607 | 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-04-30 | English | ||
| 33052576 | 8-K - DBV Technologies S.A. (0001613780) (Filer) | 2026-03-26 | English | ||
| 32895101 | 8-K - DBV TECHNOLOGIES S.A. (0001613780) (Filer) | 2026-03-02 | English | ||
| 30929652 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30929503 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30929703 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30929641 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30929668 | SCHEDULE 13G Filing | 2026-02-03 | English | ||
| 30929693 | 4 Filing | 2026-02-02 | English | ||
| 32895102 | 8-K - DBV TECHNOLOGIES S.A. (0001613780) (Filer) | 2026-01-17 | English | ||
| 12799243 | Major Shareholding Notification 2026 | 2026-01-14 | English | ||
| 12799242 | 4 | 2026-01-14 | English | ||
| 12799244 | Major Shareholding Notification 2026 | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Strong Biotechnologies, Inc
Develops and manufactures IVD products, clinical chemistry …
|
300406 | CN | Manufacturing |
|
Beijing Tiantan Biological Products Corporation Limited
Researches and produces plasma-derived medicinal products a…
|
600161 | CN | Manufacturing |
|
Beijing Tong Ren Tang Chinese Medicine Company Limited
A manufacturer and retailer of traditional Chinese medicine…
|
3613 | HK | Manufacturing |
|
BEIJING TONG REN TANG CO., LTD
Researches, manufactures, and distributes Traditional Chine…
|
600085 | CN | Manufacturing |
|
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Develops and manufactures IVD reagents and vaccines for inf…
|
603392 | CN | Manufacturing |
|
Beleave Inc.
Vertically integrated cannabis company engaged in cultivati…
|
BLEVF | CA | Manufacturing |
|
BELITE BIO, INC
Clinical-stage biopharma developing therapies for retinal a…
|
BLTE | KY | Manufacturing |
|
Benitec Biopharma Inc.
A clinical-stage biotech developing genetic medicines to si…
|
BNTC | US | Manufacturing |
|
BeOne Medicines Ltd.
Global oncology company that discovers, develops, and deliv…
|
ONC | KY | Manufacturing |
|
BEONE MEDICINES LTD.
Biopharmaceutical firm developing targeted oncology therapi…
|
688235 | CN | Manufacturing |
DBV Technologies S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33512/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33512 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33512 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33512 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33512}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DBV Technologies S.A. (id: 33512)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.